Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Argus Health
Johnson and Johnson
Healthtrust
Accenture
Merck
Dow
Covington
Queensland Health

Generated: January 19, 2019

DrugPatentWatch Database Preview

CLINDAMYCIN PHOSPHATE Drug Profile

« Back to Dashboard

Which patents cover Clindamycin Phosphate, and when can generic versions of Clindamycin Phosphate launch?

Clindamycin Phosphate is a drug marketed by Perrigo Uk Finco, Fougera Pharms, Abraxis Pharm, Alvogen Inc, Bedford, Bristol Myers Squibb, Fresenius Kabi Usa, Igi Labs Inc, Loch, Marsam Pharms Llc, Mylan Labs Ltd, Sagent Pharms, Solopak, Teva Parenteral, Watson Labs, West-ward Pharms Int, Boca Pharma Llc, Fougera Pharms Inc, G And W Labs Inc, Glasshouse Pharms, Novast Labs, Perrigo New York, Taro Pharm Inds, Teligent Pharma Inc, Vintage Pharms, Wockhardt Bio Ag, Zydus Pharms Usa Inc, Akorn, Actavis Labs Ut Inc, Mylan Pharms Inc, Perrigo Israel, Taro, Taro Pharms, Tolmar, Actavis Mid Atlantic, Baxter Hlthcare Corp, Akorn Inc, Sandoz Inc, Abbott Labs, and Baxter Hlthcare. and is included in sixty-three NDAs.

The generic ingredient in CLINDAMYCIN PHOSPHATE is clindamycin phosphate; tretinoin. There are fifty-five drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the clindamycin phosphate; tretinoin profile page.

Drug patent expirations by year for CLINDAMYCIN PHOSPHATE
Pharmacology for CLINDAMYCIN PHOSPHATE
Synonyms for CLINDAMYCIN PHOSPHATE
(2S-trans)-Methyl 7-chloro-6,7,8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-L-threo-.alpha.-D-galacto-octopyranoside 2-(dihydrogen phosphate)
[(2R,3R,4S,5R,6R)-6-(2-CHLORO-1-{[(2S,4R)-1-METHYL-4-PROPYLPYRROLIDIN-2-YL]FORMAMIDO}PROPYL)-4,5-DIHYDROXY-2-(METHYLSULFANYL)OXAN-3-YL]OXYPHOSPHONIC ACID
[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] dihydrogen phosphate
[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate
[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-{[(2S,4R)-1-methyl-4-propylpyrrolidin-2-yl]formamido}propyl]-4,5-dihydroxy-2-(methylsulfanyl)oxan-3-yl]oxyphosphonic acid
[6-[2-chloro-1-[(1-methyl-4-propyl-pyrrolidine-2-carbonyl)amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] dihydrogen phosphate
[6-[2-chloro-1-[(1-methyl-4-propylpyrrolidine-2-carbonyl)amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate
[6-[2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate
24729-96-2
6-{2-chloro-1-[(1-methyl-4-propylpyrrolidin-2-yl)carbonylamino]propyl}-4,5-dih ydroxy-2-methylthio(2H-3,4,5,6-tetrahydropyran-3-yl) dihydrogen phosphate
7(S)-Chloro-7-deoxylincomycin 2-phosphate
AB01566857_01
AC-11380
AC1L1O0X
AC1L7D1S
AC1L9EKE
AK163189
AKOS008901431
AKOS015894857
AKOS015960484
AKOS026750036
AN-7052
API0002056
AS-12554
AX8019646
BDBM241975
C11728
C18H34ClN2O8PS
CA008882
CAS-24729-96-2
CHEBI:3746
CHEMBL3184512
Cleocin phosphate
CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Cleocin T
Clinda-Derm
Clindagel
Clindamycin (phosphate)
Clindamycin 2-dihydrogen phosphate
Clindamycin 2-phosphate
Clindamycin dihydrogenphosphat
Clindamycin phosphate (JP16/USP)
Clindamycin phosphate (JP17/USP)
Clindamycin phosphate [USAN:JAN]
Clindamycin phosphate [USAN:USP:JAN]
CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%
CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Clindamycin-2-dihydrogenphosphat
CLINDAMYCIN-2-PHOSPHATE
Clindets
CS-4620
D01073
Dalacin P
Dalacin T
Dalacin-S (TN)
DR003082
DSSTox_CID_28603
DSSTox_GSID_48677
DSSTox_RID_82873
DTXSID1048677
EH6D7113I8
EINECS 246-433-0
Evoclin (TN)
HY-B1064
I06-0114
KS-00000XNT
L-threo-.alpha.-D-galacto-Octopyranoside,7,8-trideoxy-6-[[(1-methyl-4-propyl-2- pyrrolidinyl)carbonyl]amino]-1-thio-, 2-(dihydrogen phosphate), (2S-trans)-
L-threo-alpha-D-galacto-Octapyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, 2-(dihydrogen phosphate), (2S-trans)-
L-threo-alpha-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, 2-(dihydrogen phosphate), (2S-trans)-
LS-98133
Methyl (2S-trans)-7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-L-threo-alpha-D-galacto-octopyranoside, 2-(dihydrogen phosphate)
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2- pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside 2-(dihydrogen phosphate)
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside 2-(dihydrogen phosphate)
methyl 7-chloro-6,7,8-trideoxy-6-[(1-methyl-4-propylprolyl)amino]-2-O-phosphono-1-thiooctopyranoside
MFCD07793328
MFCD11982855
MolPort-006-666-188
MolPort-015-163-859
NCGC00163494-01
NCGC00166320-01
NSC-618653
NSC618653
PubChem5913
s2048
SBB071022
SCHEMBL37148
SCHEMBL718004
SR-01000872581
SR-01000872581-1
ST075182
ST24046358
SureCN718004
Tox21_113055
Tox21_113410
U 28508
U-28,508
U-28508
UFUVLHLTWXBHGZ-MGZQPHGTSA-N
UNII-EH6D7113I8
ZINC4102185

US Patents and Regulatory Information for CLINDAMYCIN PHOSPHATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott Labs CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER clindamycin phosphate INJECTABLE;INJECTION 065027-003 Jun 29, 2001 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Vintage Pharms CLINDAMYCIN PHOSPHATE clindamycin phosphate SOLUTION;TOPICAL 203343-001 May 29, 2015 AT RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Fougera Pharms CLINDAMYCIN PHOSPHATE clindamycin phosphate SOLUTION;TOPICAL 065254-001 Feb 14, 2006 AT RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Perrigo Israel CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE benzoyl peroxide; clindamycin phosphate GEL;TOPICAL 090979-001 Jun 26, 2012 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Akorn Inc CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER clindamycin phosphate INJECTABLE;INJECTION 203048-002 Apr 4, 2013 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Colorcon
Fish and Richardson
Accenture
QuintilesIMS
UBS
Chubb
Fuji
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.